SCHOTT Pharma AG & Co. KGaA (1SXP.F)

EUR 23.72

(0.08%)

Total Liabilities Summary of SCHOTT Pharma AG & Co. KGaA

  • SCHOTT Pharma AG & Co. KGaA's latest annual total liabilities in 2023 was 539.64 Million EUR , up 10.71% from previous year.
  • SCHOTT Pharma AG & Co. KGaA's latest quarterly total liabilities in 2024 Q2 was 630.92 Million EUR , up 21.29% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported annual total liabilities of 487.45 Million EUR in 2022, up 52.1% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported annual total liabilities of 320.47 Million EUR in 2021, up 14.31% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported quarterly total liabilities of 630.92 Million EUR for 2024 Q2, up 21.29% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported quarterly total liabilities of 520.18 Million EUR for 2024 Q1, down -3.61% from previous quarter.

Annual Total Liabilities Chart of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Historical Annual Total Liabilities of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 539.64 Million EUR 10.71%
2022 487.45 Million EUR 52.1%
2021 320.47 Million EUR 14.31%
2020 280.36 Million EUR 0.0%

Peer Total Liabilities Comparison of SCHOTT Pharma AG & Co. KGaA

Name Total Liabilities Total Liabilities Difference
Carl Zeiss Meditec AG 860.02 Million EUR 37.252%
Fielmann Aktiengesellschaft 1.2 Billion EUR 55.385%
Gerresheimer AG 1.95 Billion EUR 72.421%
Sartorius Aktiengesellschaft 6.99 Billion EUR 92.288%
Sartorius Aktiengesellschaft 6.99 Billion EUR 92.288%